ME-344

· MEI Pharma, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ME-344, covering 2015-06-18 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer [Phase 1]